auditory system disease: Pathological processes of the ear, the hearing, and the equilibrium system of the body.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
396 |
4. Check minimum number of eventsNone |
396 |
5. Include endpointsNone |
396 |
6. Filter based on genotype QC (FinnGen only) |
396 |
Control definitions (FinnGen only)
- Control exclude
- H8_OTHEREAR
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- H93
- Name in latin
- Aliae perceptiones auditoriae abnormes
Similar endpoints
↥List of similar endpoints to
Other abnormal auditory perceptions
based on the number of shared cases.
Similar with more cases:
- Other disorders of ear
- Diseases of the ear and mastoid process
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2549 | 1593 | 947 |
| Only index persons | 2466 | 1555 | 911 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.04 | 0.05 | 0.03 |
| Only index persons | 0.05 | 0.06 | 0.03 |
| Median age at first event (years) | |||
| Whole population | 46.50 | 48.98 | 42.40 |
| Only index persons | 46.89 | 49.24 | 42.89 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 396 | 287 | 109 |
| Unadjusted period prevalence (%) | 0.08 | 0.10 | 0.05 |
| Median age at first event (years) | 50.80 | 50.78 | 50.85 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 352
- Matched controls
- 3520
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H93.2
ICD-10 Finland
Other abnormal auditory perceptions
4503599627370496.0
323.0
351
7
H93.1
ICD-10 Finland
Tinnitus
44.5
81.2
100
31
Z01.1
ICD-10 Finland
Examination of ears and hearing
15.2
70.2
125
123
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
119.9
64.5
68
7
DFF00
NOMESCO Finland
Pure tone audiometry
22.5
60.0
89
52
N07CA01
ATC
betahistine; oral
8.5
25.2
57
78
H90.4
ICD-10 Finland
Sensorineural hearing loss, unilateral with unrestricted hearing on the contralateral side
60.6
24.4
28
5
UDC00
NOMESCO Finland
Ear microscopy
8.2
22.6
52
73
H91.2
ICD-10 Finland
Sudden idiopathic hearing loss
70.4
17.9
20
*
H91.9
ICD-10 Finland
Hearing loss, unspecified
15.5
16.1
26
18
H02
ICPC
Hearing complaint
5.2
15.9
51
111
SPAT1043
SPAT
Audiometry
4.9
12.8
42
94
H29
ICPC
Ear symptom/complaint other
3.9
11.3
48
138
Z97.4
ICD-10 Finland
Presence of external hearing-aid
29.0
10.8
14
5
DFF15
NOMESCO Finland
Speech audiometry
13.7
10.3
17
13
DFF30
NOMESCO Finland
Loudness discomfort Level (LDL)
30.9
9.5
12
*
R42
ICD-10 Finland
Dizziness and giddiness
2.4
9.0
83
398
H92.0
ICD-10 Finland
Otalgia
5.0
8.9
28
60
DE2BG
NOMESCO Finland
Acoustic channel MRI examination with high intensity magnet
+∞
8.4
8
*
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
+∞
8.4
8
*
H03
ICPC
Tinnitus, ringing/buzzing ear
9.3
8.1
16
18
L17
ICPC
Foot/toe symptom/complaint
2.2
7.9
97
527
G44.2
ICD-10 Finland
Tension-type headache
2.5
7.8
66
300
Z3229
NOMESCO Finland
Other healthcare associate professional
3.2
7.7
40
136
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.9
7.7
144
927
R01AD09
ATC
mometasone; nasal
1.9
7.7
173
1191
Z46.1
ICD-10 Finland
Fitting and adjustment of hearing aid
12.2
7.6
13
11
J01FA10
ATC
azithromycin; systemic
1.9
7.6
222
1674
H91.1
ICD-10 Finland
Presbycusis
11.2
7.4
13
12
H01
ICPC
Ear pain/earache
2.6
7.1
52
220
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
7.0
180
1282
R4160
NOMESCO Finland
Other therapy enhancing rehabilitation
6.1
7.0
18
31
H81.0
ICD-10 Finland
Ménière disease
7.8
7.0
15
20
H90.6
ICD-10 Finland
Mixed conductive and sensorineural hearing loss, bilateral
40.8
6.8
8
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.7
6.8
46
185
R51.80
ICD-10 Finland
Headache
2.2
6.5
69
349
H43.8
ICD-10 Finland
Other disorders of vitreous body
2.9
6.2
36
133
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3013707) Erythrocyte sedimentation rate by Westergren method
314
2473
2.30
10.39
4.6
3.9
mm/h
9.5
10.8
1.19
306
2308
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
325
2610
2.37
10.05
4.8
4.1
pmol/l
14.7
14.6
0.37
305
2410
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
169
1144
1.83
7.78
2.2
1.9
pmol/l
101.1
97.2
0.46
86
596
(3023103) Potassium [Moles/volume] in Serum or Plasma
376
3342
3.48
7.64
15.0
13.3
mmol/l
3.9
3.9
1.22
370
3251
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
206
1488
1.80
7.59
6.2
6.4
mmol/l
1.2
1.2
0.84
181
1268
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
357
3104
2.52
7.32
5.7
4.8
mu/l
1.8
2.2
0.54
342
2892
(3019550) Sodium [Moles/volume] in Serum or Plasma
374
3331
3.21
7.23
14.9
13.2
mmol/l
140.0
139.7
1.78
368
3248
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
187
1350
1.73
6.60
2.7
2.3
nmol/l
78.9
75.5
0.89
175
1233
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
128
830
1.80
6.57
1.3
1.3
u/ml
0.6
2.4
1.82
37
233
(3013826) Glucose [Moles/volume] in Serum or Plasma
232
1783
1.73
6.49
4.1
4.3
mmol/l
6.2
6.5
3.67
218
1651
(40768443) Skin Pathology biopsy report
32
122
2.77
6.23
1.2
1.2
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
184
1352
1.67
5.88
5.9
5.7
mmol/l
1.2
1.2
0.19
165
1248
(3019309) Folate [Moles/volume] in Red Blood Cells
82
480
1.89
5.76
1.7
1.7
nmol/l
1137.4
1228.6
0.42
65
366
(3013650) Neutrophils [#/volume] in Blood by Automated count
243
1930
1.67
5.67
8.4
9.3
e9/l
4.2
4.0
0.34
213
1685
(3001122) Ferritin [Mass/volume] in Serum or Plasma
201
1531
1.64
5.45
2.6
2.7
ug/l
99.0
90.5
0.42
190
1426
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
292
2452
1.73
5.35
7.0
7.1
u/l
75.7
78.7
0.71
274
2318
(40761511) CBC panel - Blood by Automated count
381
3510
3.26
5.31
13.0
11.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
220
1723
1.62
5.26
5.9
6.2
e9/l
0.2
0.2
0.04
196
1527
(3022145) Colonoscopy Study observation
63
349
1.96
5.19
1.4
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
335
2950
1.88
4.94
5.0
5.1
mmol/mol
37.9
38.9
1.76
313
2781
(3001604) Monocytes [#/volume] in Blood
212
1661
1.59
4.94
5.6
5.8
e9/l
0.5
0.6
1.30
182
1439
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
368
3356
2.37
4.83
15.4
12.0
mg/l
19.3
20.9
0.49
311
2590
(3006315) Basophils [#/volume] in Blood
211
1667
1.57
4.64
5.7
5.8
e9/l
0.0
0.0
0.20
183
1442
(3019198) Lymphocytes [#/volume] in Blood
216
1716
1.57
4.63
5.8
5.8
e9/l
1.8
2.0
1.48
193
1525
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
31
136
2.39
4.58
3.2
2.2
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
110
747
1.65
4.55
1.4
1.4
g/l
2.1
2.2
0.48
69
465
(3006504) Eosinophils/100 leukocytes in Blood
199
1556
1.56
4.55
5.7
5.8
%
3.0
2.8
0.46
184
1452
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
25
100
2.60
4.47
1.0
1.1
u/ml
1.5
12.3
—
6
14
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
380
3533
2.87
4.47
10.8
9.6
u/l
25.5
25.6
0.02
369
3437
(3019069) Monocytes/100 leukocytes in Blood
199
1563
1.55
4.41
6.1
6.1
%
8.3
8.3
0.05
184
1470
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
110
753
1.64
4.39
1.7
1.8
mg/l
0.8
1.1
1.01
81
566
(3024561) Albumin [Mass/volume] in Serum or Plasma
166
1255
1.56
4.35
4.0
4.4
g/l
37.2
36.3
1.22
161
1188
(3037467) Urinalysis macro (dipstick) panel - Urine
268
2255
1.58
4.33
4.7
3.9
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
22
4.64
4.32
1.0
1.0
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
193
1511
1.54
4.31
5.9
5.8
%
0.7
0.7
0.05
178
1407
(3022948) Iron [Moles/volume] in Serum or Plasma
73
452
1.75
4.22
1.7
2.2
umol/l
14.0
13.3
0.36
66
423
(3048689) Calprotectin [Mass/mass] in Stool
74
464
1.73
4.09
2.4
2.3
ug/g
92.5
106.4
0.19
61
363
(3002030) Lymphocytes/100 leukocytes in Blood
202
1612
1.52
4.04
5.9
5.9
%
28.7
28.8
0.02
186
1513
(3018010) Neutrophils/100 leukocytes in Blood
200
1593
1.52
4.03
5.6
5.7
%
56.5
56.7
0.10
184
1502
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
121
864
1.58
4.02
1.7
1.7
mmol/l
1.3
1.4
0.88
115
747
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
145
1096
1.51
3.67
3.4
3.2
ng/l
18.6
32.2
1.88
73
671
(40768797) Stomach Pathology biopsy report
67
425
1.69
3.54
1.1
1.2
—
—
—
0
0
(3019225) pH of Specimen
44
247
1.88
3.49
3.2
4.6
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
200
1626
1.46
3.46
4.8
6.2
umol/l
10.4
10.6
0.14
186
1545
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
268
2309
1.50
3.44
2.9
2.8
u/l
38.1
40.5
0.33
253
2187
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
88
607
1.58
3.33
1.4
1.3
u/ml
4.7
8.9
0.61
38
246
(3044889) 12 lead EKG panel
258
2220
1.47
3.22
3.6
3.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
71
471
1.62
3.15
1.5
1.4
titre
338.5
522.7
0.83
13
103
(3019060) Gas panel - Arterial blood
30
155
2.01
3.04
4.1
4.2
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
5
5
10.10
2.98
1.2
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
11
35
3.20
2.95
1.6
2.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
87
618
1.52
2.87
1.4
1.3
iu/ml
18.9
34.3
1.44
25
207
(3005322) IgE [Units/volume] in Serum or Plasma
38
218
1.82
2.84
1.2
1.2
u/ml
146.1
152.7
0.03
38
204
(40768804) Tissue Pathology biopsy report
164
1322
1.41
2.80
2.3
2.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
339
3120
1.60
2.76
3.8
3.7
mmol/l
1.3
1.3
0.19
317
2911
(3044290) Cell count panel - Cerebral spinal fluid
16
66
2.48
2.74
1.3
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
354
3295
1.70
2.73
4.9
4.5
mmol/l
2.9
2.8
0.67
333
3082
(3017446) Testosterone [Moles/volume] in Serum or Plasma
32
176
1.89
2.73
2.2
2.2
nmol/l
15.7
12.8
1.28
27
160
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
274
2419
1.43
2.73
3.9
3.4
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
350
3251
1.66
2.69
4.6
4.1
mmol/l
4.8
4.8
0.47
328
3062
(36304419) Bacteria [Presence] in Urine
114
872
1.43
2.58
3.9
2.7
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
26
136
1.98
2.57
2.4
1.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
5
7
7.22
2.55
1.6
1.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
135
1066
1.40
2.55
6.1
5.8
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
35
203
1.79
2.54
1.3
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
195
1642
1.37
2.48
4.6
4.5
estimate
0.0
0.0
0.50
34
322
(3019897) Erythrocyte distribution width [Ratio] by Automated count
12
45
2.72
2.47
1.8
2.1
%
13.8
13.2
0.53
12
45
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
23
117
2.03
2.46
1.1
1.1
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
82
594
1.48
2.45
1.4
1.7
pmol/l
458.0
9524247.9
0.50
64
525
(3036481) Cortisol [Moles/volume] in Serum or Plasma
48
308
1.64
2.44
2.3
2.1
nmol/l
417.8
373.9
1.08
41
288
(3023368) Bacteria identified in Blood by Culture
98
737
1.44
2.42
3.9
3.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
23
118
2.01
2.40
1.2
1.1
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
46
294
1.64
2.38
5.2
7.5
mmol/l
1.3
1.2
0.05
36
237
(3032080) INR in Blood by Coagulation assay
139
1114
1.38
2.38
5.3
5.9
inr
1.1
1.1
0.06
36
362
(3033658) Prothrombin time (PT) actual/Normal
106
811
1.42
2.38
3.2
3.5
%
100.2
95.1
1.75
99
792
(42529406) Shigella sp [Presence] in Stool by Culture
23
119
1.99
2.35
1.2
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
122
958
1.40
2.35
4.3
2.8
e6/l
13.0
55.7
3.04
99
729
(3009261) Glucose [Presence] in Urine by Test strip
196
1664
1.35
2.31
3.5
3.3
estimate
0.0
0.0
0.00
32
308
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
99
752
1.42
2.30
1.9
2.1
—
—
—
0
0
(3022621) pH of Urine by Test strip
35
210
1.73
2.29
2.9
2.5
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
346
3231
1.56
2.28
4.5
4.0
mmol/l
1.5
1.5
0.07
326
3023
(3013512) EKG study
103
790
1.41
2.27
4.1
3.4
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
113
882
1.39
2.25
4.2
2.7
e6/l
0.1
0.5
4.09
93
657
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
121
958
1.38
2.21
2.1
2.4
u/l
52.6
55.8
0.40
113
895
(3018095) Leukocytes [#/volume] in Urine
141
1145
1.36
2.19
4.9
3.3
e6/l
26.1
84.3
1.82
105
783
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
8
24
3.38
2.19
3.8
3.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
35
213
1.71
2.18
2.3
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
32
190
1.74
2.18
2.8
3.3
ng/l
67.8
197.8
3.82
32
175
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
56
384
1.53
2.17
1.6
2.2
%
25.6
22.5
0.76
48
339
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
338
3151
1.50
2.14
4.5
4.1
mmol/l
5.7
5.8
1.14
320
2917
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
98
754
1.40
2.11
2.3
2.0
mg/l
2.6
3.0
1.02
90
636
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
98
756
1.39
2.08
1.8
1.6
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
5
10
5.05
2.07
1.4
1.0
%
90.2
94.9
—
5
10
(3013727) Leukocytes other/100 leukocytes in Blood
5
10
5.05
2.07
3.4
3.0
%
58.2
55.9
—
5
10
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
5
10
5.05
2.07
1.4
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
109
857
1.38
2.06
7.5
7.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
179
1518
1.33
2.05
8.3
8.6
e9/l
0.0
0.0
0.60
149
1239
(4010399)
36
225
1.66
2.05
1.2
1.5
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
71
519
1.45
2.03
4.0
2.5
e6/l
0.8
0.9
0.28
45
284
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
75
554
1.44
2.03
5.8
3.7
ng/l
55.3
254.0
2.12
51
396
(3016018) Differential panel - Cerebral spinal fluid
8
26
3.12
2.02
1.5
1.7
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
136
1110
1.34
2.02
4.1
2.8
—
—
—
0
0
(4062490)
9
32
2.85
2.01
2.2
1.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
31
188
1.70
1.97
1.0
1.1
—
195.0
—
0
6
(3035350) Ketones [Presence] in Urine by Test strip
190
1633
1.31
1.96
3.4
3.3
estimate
0.0
0.0
0.00
32
319
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
48
326
1.54
1.95
2.2
2.4
u/l
28.1
30.6
0.34
40
277
(3021960) Folate [Moles/volume] in Serum or Plasma
89
684
1.39
1.92
1.6
1.5
nmol/l
19.5
21.7
0.83
76
591
(3008898) HLA-B27 [Presence]
28
167
1.73
1.89
1.0
1.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
46
312
1.54
1.89
1.7
1.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
33
207
1.65
1.87
1.1
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
134
1103
1.32
1.86
3.5
3.1
u/l
27.1
30.6
1.65
129
1054
(3042936) Bacteria identified in Isolate by Culture
57
407
1.47
1.84
2.4
2.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
14
66
2.16
1.84
1.0
1.0
u/ml
1.9
2.4
—
6
30
(3000850) Epithelial cells [#/volume] in Urine
86
664
1.38
1.81
2.8
2.3
e6/l
4.4
6.7
0.71
76
587
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
8
29
2.79
1.80
1.1
1.2
—
65.0
—
0
6
(3044640) Blood type and Crossmatch panel - Blood
123
1007
1.32
1.76
2.0
2.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
22
125
1.80
1.76
2.0
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
313
2908
1.36
1.74
18.7
15.0
%
13.5
13.6
0.15
307
2863
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
8
30
2.70
1.73
1.0
1.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
17
90
1.93
1.68
1.6
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
175
1512
1.28
1.65
3.5
3.7
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
65
487
1.40
1.63
4.5
2.6
e6/l
2.8
2.9
0.05
38
252
(3000494) Fungus identified in Specimen by Culture
53
383
1.44
1.62
1.5
1.3
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
23
137
1.72
1.59
1.3
1.5
—
9.2
—
0
6
(3009542) Hematocrit [Volume Fraction] of Blood
333
3139
1.38
1.57
16.6
13.1
%
40.0
40.1
0.03
251
2464
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
14
71
2.01
1.56
1.2
1.2
u/ml
2.7
1.6
—
6
29
(3001019) Free T4 and TSH panel - Serum or Plasma
12
230
0.51
1.54
1.7
1.7
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
21
2.88
1.51
1.2
1.5
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
13
65
2.03
1.50
2.4
2.0
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
22
2.75
1.44
1.2
1.2
—
—
—
0
0
(4027681)
6
22
2.75
1.44
1.2
1.1
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
17
96
1.81
1.41
1.4
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
35
240
1.50
1.40
3.2
2.7
ml/min/173m2
72.5
71.1
0.08
13
99
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
22
135
1.67
1.39
7.5
9.5
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
44
317
1.44
1.39
1.8
1.8
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
109
907
1.28
1.35
3.3
2.6
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
11
54
2.07
1.34
2.6
1.5
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
46
337
1.41
1.33
4.3
3.9
%
33.6
32.4
0.34
31
227
(3011397) Hemoglobin [Presence] in Urine by Test strip
91
743
1.29
1.31
3.6
3.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
6
24
2.52
1.31
1.8
2.4
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
8
34
2.38
1.30
1.0
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
8
34
2.38
1.30
1.1
1.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
71
561
1.32
1.29
5.1
4.5
ug/l
1.7
2.1
0.53
66
502
(3051651) Icteric interference index of Serum or Plasma
5
18
2.80
1.29
1.8
2.1
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
18
2.80
1.29
1.0
1.2
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
8
35
2.31
1.27
1.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
32
221
1.49
1.26
1.2
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
20
124
1.65
1.23
1.6
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
22
140
1.61
1.23
3.3
3.1
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
5
19
2.65
1.22
1.0
1.4
mmol/l
1.9
1.9
—
5
19
(3015377) Calcium [Moles/volume] in Serum or Plasma
125
1071
1.24
1.20
2.6
3.3
mmol/l
2.4
2.4
0.49
113
973
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
90
742
1.28
1.20
3.1
3.1
ng/l
577.5
856.5
1.52
78
632
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
26
2.33
1.19
1.0
1.3
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
32
224
1.47
1.19
1.4
2.8
e9/l
63.1
71.1
1.40
26
166
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
14
79
1.80
1.18
1.1
1.1
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
11
57
1.96
1.18
1.2
1.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
31
216
1.47
1.18
1.3
1.3
—
—
—
0
0
(40761535) Cells panel - Urine sediment
33
234
1.45
1.15
3.2
3.1
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
58
454
1.33
1.14
1.8
1.8
—
—
—
0
0
(3018418) pH of Serum or Plasma
112
955
1.24
1.12
3.2
3.6
ph
7.4
7.4
1.09
15
183
(3014148) Varicella zoster virus Ab [Titer] in Serum
10
51
1.99
1.12
1.1
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
37
271
1.40
1.09
3.7
3.9
%
0.0
0.1
—
10
74
(21494434) Karyotype in Bone marrow
5
21
2.40
1.09
1.0
1.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
62
494
1.30
1.08
2.1
3.6
mmol/l
0.8
0.8
0.04
57
467
(3026493) Urate [Moles/volume] in Serum or Plasma
90
752
1.25
1.08
2.9
2.5
umol/l
322.0
8225.6
3.76
78
663
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
24
162
1.51
1.07
1.5
1.4
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
22
2.29
1.03
1.4
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
9
47
1.94
1.02
1.3
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
45
345
1.34
1.02
1.5
1.5
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
12
68
1.79
1.01
1.8
1.2
—
—
—
0
0
(3012544) pH of Venous blood
36
267
1.38
1.00
4.0
3.8
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
95
807
1.23
0.98
4.2
4.6
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
23
2.19
0.98
1.0
1.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
50
393
1.31
0.97
2.2
1.7
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
35
261
1.37
0.95
3.7
3.9
%
0.0
0.0
—
8
66
(3020891) Body temperature
15
93
1.64
0.95
2.2
4.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
37
1.91
0.94
1.3
1.5
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
7
37
1.91
0.94
1.0
1.1
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
7
37
1.91
0.94
2.4
4.0
u/ml
17.2
49.6
—
7
37
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
27
2.24
0.94
1.2
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
81
951
0.81
0.90
1.5
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
31
411
0.73
0.89
1.2
1.4
—
—
—
0
0
(3026782) Osmolality of Urine
74
621
1.24
0.86
3.3
2.4
mosm/kgh2o
504.2
548.3
0.75
63
529
(36660697) Celiac disease serology panel - Serum
37
284
1.33
0.85
1.1
1.2
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
6
31
1.95
0.84
2.2
3.5
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
34
259
1.34
0.83
3.9
3.9
mmol/l
2.7
2.1
0.77
27
210
(3004809) Band form neutrophils/100 leukocytes in Blood
8
47
1.72
0.81
2.6
2.7
%
0.3
1.2
—
8
39
(1002224) Polysomnography panel
23
165
1.42
0.79
1.1
1.1
—
—
—
0
0
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
6
33
1.83
0.79
2.0
2.3
nmol/l
2.0
3.1
—
6
33
(3023419) Bacteria identified in Sputum by Culture
6
33
1.83
0.79
3.2
2.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
37
289
1.31
0.77
3.7
3.8
%
0.9
0.8
—
10
84
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
28
0.00
0.76
0.0
1.2
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
9
53
1.71
0.76
1.0
1.2
—
—
—
0
0
(3005082) Progesterone [Moles/volume] in Serum or Plasma
5
24
2.10
0.74
1.0
1.2
nmol/l
51.2
34.8
—
5
19
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
64
538
1.23
0.74
2.5
2.8
mmol/l
2.4
2.4
0.88
58
483
(3021447) Carbon dioxide [Partial pressure] in Venous blood
34
264
1.31
0.74
4.0
3.8
kpa
6.0
5.8
0.52
34
259
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
23
168
1.39
0.73
2.4
2.3
u/l
3861.3
2363.1
—
8
70
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
55
456
1.24
0.73
4.9
4.1
%
22.9
22.0
0.17
22
208
(3025018) Bordetella pertussis Ab [Titer] in Serum
5
25
2.01
0.73
1.6
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
10
60
1.68
0.72
1.1
1.1
u/ml
1.0
2.6
—
5
27
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.71
3.2
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
26
1.93
0.71
3.2
1.1
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
9
58
1.56
0.70
1.1
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
9
58
1.56
0.70
1.8
1.9
—
—
—
0
0
(4281824)
7
41
1.72
0.70
1.1
1.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
11
69
1.61
0.69
1.7
1.6
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
34
268
1.29
0.68
3.1
3.8
%
0.7
0.4
—
6
59
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
320
3088
1.19
0.67
12.4
11.0
ml/min/173m2
86.5
85.9
0.20
278
2522
(3029937) Albumin [Presence] in Urine by Test strip
99
877
1.17
0.66
3.9
3.5
estimate
0.0
0.0
0.50
35
315
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
5
28
1.80
0.66
1.2
1.1
—
5.9
—
0
7
(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma
5
28
1.80
0.66
1.2
1.5
ug/l
12.9
16.5
—
5
28
(3019150) Specific gravity of Urine by Refractometry
83
725
1.18
0.66
3.5
3.3
kg/l
1.0
1.0
0.09
20
99
(4034850)
15
103
1.47
0.66
6.4
9.4
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
44
1.60
0.65
1.0
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
5
29
1.73
0.64
1.4
1.2
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
29
226
1.31
0.63
2.9
2.8
e9/l
3.5
3.9
0.50
20
192
(3027945) Reticulocytes/100 erythrocytes in Blood
38
308
1.26
0.62
1.8
3.0
%
1.6
1.7
0.62
29
282
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
20
0.00
0.60
0.0
1.1
—
0.3
—
0
15
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
20
0.00
0.60
0.0
1.1
—
—
—
0
0
(3000991) Gas panel - Venous blood
29
228
1.29
0.60
6.0
8.4
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
30
238
1.28
0.59
1.6
1.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
116
1275
0.87
0.58
2.7
2.7
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
14
98
1.44
0.57
1.5
1.7
iu/ml
0.0
0.0
—
5
14
(3026389) Candida sp identified in Specimen by Organism specific culture
6
36
1.68
0.57
1.0
1.2
—
—
—
0
0
(3000492) Spirometry study
42
349
1.23
0.57
1.5
1.5
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
5
89
0.56
0.56
6.4
5.3
mg/l
1.0
1.3
—
5
84
(3025130) Human papilloma virus identified in Specimen
8
55
1.46
0.56
2.5
1.8
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
6
39
1.55
0.53
3.3
1.6
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
9
64
1.42
0.52
1.1
1.3
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
16
118
1.37
0.51
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
16
118
1.37
0.51
1.6
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
16
118
1.37
0.51
1.6
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
16
118
1.37
0.51
1.6
1.7
—
215.0
—
0
8
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
16
118
1.37
0.51
1.6
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
36
430
0.82
0.50
1.5
1.5
—
—
—
0
0
(4094501)
11
76
1.46
0.48
1.2
1.0
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
11
76
1.46
0.48
1.1
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
48
412
1.19
0.48
1.2
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
19
243
0.77
0.47
1.9
1.7
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
28
228
1.25
0.46
3.1
6.9
mmol/l
6.6
8.2
1.17
28
217
(3052851) Hemolysis interference index of Serum or Plasma
13
95
1.38
0.44
2.5
2.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
13
95
1.38
0.44
1.2
1.3
—
3.7
—
0
10
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
8
56
1.44
0.43
1.5
2.3
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
13
96
1.37
0.42
1.2
1.3
—
8.2
—
0
17
(40768795) Lymph node Pathology biopsy report
5
33
1.52
0.41
1.0
1.2
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
40
344
1.18
0.41
3.5
2.8
ug/l
1.3
0.8
0.40
30
212
(3029075) Extractable nuclear Ab panel - Serum
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
13
97
1.35
0.40
1.7
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
13
97
1.35
0.40
1.6
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
10
71
1.42
0.39
4.2
4.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
35
1.43
0.39
1.0
1.3
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
9
66
1.37
0.38
1.8
3.4
e9/l
3.4
4.5
—
9
66
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
9
68
1.33
0.38
2.0
3.8
%
50.9
56.8
—
9
68
(1001926) Buprenorphine [Presence] in Urine by Screen method
17
134
1.28
0.37
1.8
1.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
69
1.31
0.37
1.9
1.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
26
308
0.83
0.35
2.8
2.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
26
308
0.83
0.35
2.0
1.8
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
6
44
1.37
0.34
1.3
1.4
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
6
44
1.37
0.34
1.3
1.3
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
6
44
1.37
0.34
1.0
1.0
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
13
100
1.31
0.34
1.2
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
26
219
1.20
0.34
1.5
1.5
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
6
45
1.34
0.34
1.0
1.4
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
6
87
0.68
0.33
36.8
5.2
kpa
9.0
8.6
—
6
81
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
16
128
1.26
0.32
1.4
1.9
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
11
83
1.33
0.32
2.2
1.7
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
13
101
1.30
0.32
1.6
1.5
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
52
1.35
0.31
1.3
1.5
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
15
120
1.26
0.30
16.8
5.4
mmol/l
24.7
25.2
0.69
15
114
(3011288) Drugs identified in Urine by Screen method
15
120
1.26
0.30
2.3
1.9
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
7
54
1.30
0.30
4.1
1.9
%
74.8
61.2
—
7
54
(40760888) Immunoglobulin light chains.free panel - Serum
7
56
1.25
0.29
4.1
3.9
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
34
298
1.15
0.29
3.5
4.2
ug/l
9.0
21.5
0.37
25
245
(3000475) Leukocytes [#/volume] in Synovial fluid
8
62
1.30
0.28
1.6
1.4
e6/l
24907.0
18897.4
—
8
46
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
8
63
1.28
0.28
2.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
8
63
1.28
0.28
2.3
1.3
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
16
131
1.23
0.27
1.6
1.5
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
38
338
1.14
0.27
6.3
5.9
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
8
65
1.24
0.27
2.5
3.0
mmol/l
1.3
1.5
—
8
65
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
8
66
1.22
0.27
1.3
1.3
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
11
86
1.29
0.26
1.4
2.2
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
5
71
0.70
0.26
1.0
2.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
53
484
1.11
0.26
2.1
2.0
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
18
151
1.20
0.25
1.5
1.4
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
74
1.22
0.25
1.2
1.6
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
9
74
1.22
0.25
1.6
2.3
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
38
341
1.13
0.24
1.9
1.7
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
15
124
1.22
0.24
1.8
1.4
g/l
0.2
0.2
0.02
15
117
(3016879) Cocaine [Presence] in Urine
18
152
1.19
0.24
1.9
1.5
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
57
525
1.10
0.24
2.2
2.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
25
285
0.87
0.23
3.0
3.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
133
1271
1.07
0.23
3.6
3.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
5
38
1.32
0.23
1.4
1.4
nmol/l
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
39
1.29
0.23
2.0
1.6
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
5
39
1.29
0.23
1.2
1.4
pmol/l
284.4
430.4
—
5
30
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
34
378
0.89
0.23
1.9
2.4
umol/l
11.5
7.8
0.30
29
321
(3021387) Prolactin [Units/volume] in Serum or Plasma
18
153
1.18
0.22
1.7
1.5
mu/l
243.7
306.6
0.80
18
138
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
40
1.25
0.22
1.8
2.6
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
5
40
1.25
0.22
1.8
2.6
mmol/l
107.2
105.7
—
5
40
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
5
40
1.25
0.22
1.0
1.3
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
5
40
1.25
0.22
1.8
2.6
mmol/l
4.1
4.0
—
5
40
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
14
116
1.21
0.22
1.4
1.3
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
13
107
1.22
0.22
3.5
4.7
g/l
0.1
0.4
—
6
44
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.5
—
13.5
—
0
11
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
0
11
0.00
0.21
0.0
1.2
—
406.8
—
0
6
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
29.6
—
0
11
(4035726)
30
268
1.13
0.21
1.5
1.4
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
0
12
0.00
0.21
0.0
5.2
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
7.9
—
0
12
(3004451) EKG impression Narrative
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
0
12
0.00
0.21
0.0
1.5
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
5
43
1.16
0.21
2.0
2.7
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
6
48
1.25
0.20
1.0
1.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
6
48
1.25
0.20
1.0
1.3
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
13
108
1.21
0.20
1.5
1.9
—
—
—
0
0
(3017704) Immunofixation for Urine
0
14
0.00
0.20
0.0
1.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
7
59
1.19
0.18
4.3
2.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
7
59
1.19
0.18
2.7
3.2
mmol/l
7.2
7.3
—
7
59
(3007566) Smooth muscle Ab [Titer] in Serum
10
82
1.23
0.17
1.1
1.3
—
80.0
—
0
5
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
15
129
1.17
0.17
1.7
1.4
g/l
1.1
1.2
1.32
15
120
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
67
0.74
0.17
1.2
1.5
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
8
70
1.15
0.16
1.3
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
26
287
0.90
0.16
1.3
1.4
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
71
1.13
0.16
1.3
1.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
88
0.79
0.14
1.1
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
14
122
1.15
0.14
2.9
3.5
%
50.4
53.3
0.16
14
122
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
15
132
1.14
0.13
1.3
2.0
—
—
—
0
0
(3009343) pH of Capillary blood
20
181
1.11
0.12
13.2
4.6
—
7.4
—
0
22
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
18
162
1.12
0.12
2.1
1.6
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
12
105
1.15
0.11
2.4
1.8
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
18
163
1.11
0.11
1.9
1.5
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
20
183
1.10
0.10
13.2
4.6
kpa
5.0
5.2
0.43
20
169
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
59
614
0.95
0.09
1.7
1.6
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
69
715
0.96
0.09
1.7
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
5
47
1.06
0.09
2.0
1.3
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
5
48
1.04
0.09
1.0
1.1
—
19.5
—
0
15
(3028300) Cannabinoids [Presence] in Urine
18
165
1.10
0.09
1.9
1.5
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
18
165
1.10
0.09
1.9
1.5
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
18
165
1.10
0.09
1.9
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
6
56
1.07
0.08
1.5
1.1
—
—
—
0
0
(4306422)
5
60
0.83
0.08
1.0
1.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
64
0.78
0.08
1.0
1.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
5
64
0.78
0.08
1.0
1.5
—
118.6
—
0
11
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
68
1.03
0.08
1.1
1.3
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
8
77
1.04
0.07
4.1
3.6
mg/l
35.3
30.1
—
8
58
(3034860) Kappa light chains.free [Mass/volume] in Serum
8
77
1.04
0.07
4.1
3.6
mg/l
27.6
118.2
—
8
60
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
83
0.84
0.07
1.1
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
11
122
0.90
0.07
1.2
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
17
159
1.07
0.05
1.2
1.4
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
42
432
0.97
0.04
1.6
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
87
856
1.02
0.04
3.4
4.0
mg/mmol
1.4
10.0
4.89
49
521
(46235355) HIV 1 and 2 tests - Meaningful Use set
76
749
1.02
0.02
2.1
1.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
13
123
1.06
0.01
1.2
1.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
93
939
0.99
0.01
3.0
2.9
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
28
282
0.99
0.00
1.1
1.2
iu/ml
136.9
166.9
—
9
128
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
11
111
0.99
0.00
1.4
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
14
139
1.01
0.00
16.6
4.8
—
—
—
0
0
(40768793) Breast Pathology biopsy report
10
103
0.97
0.00
1.4
1.3
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
11
107
1.03
0.00
1.1
2.0
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
81
814
0.99
0.00
2.9
3.2
mg/l
11.4
305.8
1.40
48
512
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
12
124
0.97
0.00
1.9
1.8
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
18
184
0.98
0.00
2.7
2.3
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
5
53
0.94
0.00
1.4
2.1
u/ml
2.4
84.4
—
5
48
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
7
0.00
0.00
0.0
5.1
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.3
—
1.6
—
0
7
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
0
7
0.00
0.00
0.0
2.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
110
1.00
0.00
2.1
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
6
0.00
0.00
0.0
3.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
5
51
0.98
0.00
2.0
1.2
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
4.2
—
3.5
—
0
5
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
80
1.00
0.00
1.5
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
4.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
43
430
1.00
0.00
1.7
1.7
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
5
52
0.96
0.00
2.2
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
5
56
0.89
0.00
1.2
1.0
—
—
—
0
0
(3027653) Mycophenolate [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
2.8
—
2.2
—
0
5
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
5
0.00
0.00
0.0
4.6
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
63
0.95
0.00
1.0
1.3
—
—
—
0
0
(3024932) HLA-DR beta [Type]
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
12.5
—
45.5
—
0
6
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
5
0.00
0.00
0.0
3.0
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
5
57
0.88
0.00
1.0
1.9
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
57
0.88
0.00
1.0
1.5
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
6
68
0.88
0.00
1.8
3.0
mmol/l
26.8
24.9
—
6
59
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
7
75
0.93
0.00
4.6
3.6
—
1.2
—
0
8
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
8
0.00
0.00
0.0
1.9
—
—
—
0
0
(3012501) Base excess in Blood by calculation
5
59
0.85
0.00
1.2
1.7
mmol/l
2.6
2.7
—
5
43
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
93
930
1.00
0.00
3.1
3.2
mmol/l
7.8
7.7
0.10
76
790
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
52
0.96
0.00
1.0
1.6
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
7
77
0.91
0.00
2.4
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
8
79
1.01
0.00
1.3
1.5
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
2.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
9
93
0.97
0.00
1.8
1.6
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
3.4
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint H8_ABNAUDPER and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| H8_ABNAUDPER | 0.748 [0.58, 0.96] | 0.025 |
| Birth year | 0.998 [0.99, 1.01] | 0.628 |
During the follow-up period (1.1.1998 — 31.12.2019), 73 out of 1328 females with H8_ABNAUDPER died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have H8_ABNAUDPER.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.074% | No data |
| 5 | 0.432% | No data |
| 10 | 1.122% | No data |
| 15 | 2.294% | No data |
| 20 | 4.246% | No data |
Relationships between endpoints
↥Index endpoint: H8_ABNAUDPER – Other abnormal auditory perceptions
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data